Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 6Leukemia, Myeloid, Acute 3Carcinoma, Non-Small-Cell Lung 3Neoplasms 2Kidney Neoplasms 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Skin Neoplasms 1Recurrence 1Radiation Injuries 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Pleural Effusion, Malignant 1Platinum Resistant Ovarian Cancer 1Ovarian Neoplasms 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Mycosis Fungoides 1Melanoma 1Lymphopenia 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell, Marginal Zone 1Lung Neoplasms 1Hot Flashes 1Hodgkin Disease 1Gangliosidosis, GM1 1Gangliosidoses 1Fatigue 1

Interventions

Cyclophosphamide 9fludarabine 8Interleukin-2 8aldesleukin 7Sunitinib 6Everolimus 6Bevacizumab 6fludarabine phosphate 5Sorafenib 5Radiotherapy 4Nivolumab 4Gene Expression Profiling 4Filgrastim 4pembrolizumab 3peginterferon alfa-2b 3Stem Cell Transplantation 3Radiotherapy, Intensity-Modulated 3Peripheral Blood Stem Cell Transplantation 3Melphalan 3Immunohistochemistry 3Granulocyte Colony-Stimulating Factor 3cabozantinib 2atezolizumab 2Thiotepa 2Sodium Chloride 2Reverse Transcriptase Polymerase Chain Reaction 2Polymerase Chain Reaction 2Mycophenolic Acid 2Mesna 2Immunoenzyme Techniques 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Kidney Neoplasms × Sodium Chloride × Clear all
NCT03824808 2023-10-25

Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery

University of Missouri-Columbia

Phase 4 Terminated
21 enrolled 12 charts
Genitourinary

Kidney Neoplasms, Prostatic Neoplasms

NCT01486550 2014-10-09

VONE

Regional Hospital Holstebro

Phase 4 Terminated
14 enrolled
Genitourinary

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡